Interleukin-6 receptor (IL-6R), when activated, leads to the regulation of the immune response, acute-phase reactions, and hematopoiesis. This receptor may be involved in a number of diseases including multiple myeloma, autoimmune diseases, and prostate cancer.
Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma (2023)Shadi Chamseddine, Yehia I. Mohamed, Sunyoung S. Lee, James C. Yao, Clinical Translational Research
Carbon nanotube and nanofiber exposure and sputum and blood biomarkers of early effect among U.S. workers (2018)Beard JD, Erdely A, Dahm MM, de Perio MA, Birch ME, Evans DE, Fernback JE, Eye T, Kodali V, Mercer RR, Bertke SJ, Schubauer-Berigan MK Environmental Internation 116 (2018)
Dendritic cell immunotherapy followed by cART interruption during HIV-1 infection induces plasma protein markers of cellular immunity and neutrophil recruitment (2018)van den Ham HJ, Cooper J, Tomasik J, Bahn S, Aerts J, Oseterhaus A, Gruters R, Andeweg A PLoS One
Variation in Serum Biomarkers with Sex and Female Hormonal Status: Implications for Clinical Tests (2016)Ramsey JM, Cooper JD, Penninx BWJH, Bahn S Scientific Reports
A Subset of Cerebrospinal Fluid Proteins from a Multi-Analyte Panel Associated with Brain Atrophy, Disease Classification and Prediction in Alzheimers Disease. (2015)Khan W, Aguilar C, Kiddle SJ, Doyle O, Thambisetty M, Muehlboeck S, Sattlecker M, Newhouse S, Lovestone S, Dobson R, Giampietro V, Westman E, Simmons A PLoS One